Clinical efficacy of avatrombopag and recombinant human thrombopoietin in the treatment of chronic liver disease-associated severe thrombocytopenia: A real-world study

• Main Authors: Yong-Shuai Wang (Author), Wei Wang (Author), Sai Zhang (Author), Shen-Yu Zhang (Author), Ai-Zong Shen (Author), Hua-Chuan Song (Author), Huan-Zhang Yao (Author), Rui-Peng Song (Author), Fan-Zheng Meng (Author), Lei Li (Author), Bjoern Nashan (Author), Ji-Zhou Wang (Author), Lian-Xin Liu (Author)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Purpose: To investigate the clinical efficacy of avatrombopag, an oral thrombopoietin receptor agonist, versus subcutaneous recombinant human thrombopoietin (rh-TPO) in the treatment of severe thrombocytopenia (TCP) associated with chronic liver disease (CLD).Methods: Clinical data of 250 patients w...